For Research Use Only. The KLOW peptide blend is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.
What Research Grade KLOW Supply Requires
KLOW is the most analytically complex blend product in the Midwest Peptide catalog because it combines four distinct research peptides at defined ratios. Research grade supply has to address the analytical characterization of each of the four components and the ratio of the components in the blend. The analytical methods have to resolve and quantify all four peptides in the same sample.
The four peptides in KLOW have different sequences, different masses, different chromatographic retention times, and different chemical properties. Appropriately designed HPLC methods can resolve and quantify each, and mass spectrometric methods can confirm the identity of each. The combined analytical package requires more sophisticated development than single peptide characterization but is achievable at research grade standards with third party laboratory support.
Midwest Peptide supplies KLOW 90mg with third party certificates of analysis that address the four peptide characterization and the blend ratio documentation.
Sourcing Criteria for Research Grade KLOW
Third party certificate of analysis. Independent analytical verification with lot specific values for each of the four peptides and for the blend ratio.
Component identity confirmation. Each of the four peptides should be identified by mass spectrometry with the observed mass matching the theoretical mass of the specific compound.
Component purity specification. Each of the four peptides should be supplied at research grade purity with the individual purity values documented on the certificate.
Ratio documentation. The ratio of the four peptides in the blend should be defined and documented.
Lot traceability. Every vial carries a lot number that traces to the production batch.
Research use only compliance. The KLOW peptide blend research overview covers the preclinical research applications including GHK-Cu contribution, BPC-157 contribution, TB-500 contribution, KPV contribution, anti-inflammatory research, and angiogenesis research.
Shipping. Domestic shipping from Mission, Kansas through ShipStation and UPS.
Payment flexibility. Zelle (five percent discount), CashApp, Venmo, Azeban Pay, and Coinbase Commerce.
Research support. Direct support through 636-734-2390.
Red Flags When Evaluating KLOW Suppliers
No ratio documentation. The ratio of the four peptides has to be defined for reproducible research use.
Component identity not confirmed for each peptide. Each of the four peptides requires explicit identification.
Purity below research grade for any component. Each component requires a defined purity specification with lot specific values.
Internal certificate only. Third party verification is the research grade standard.
Conflation with GLOW. KLOW and GLOW are distinct blend products. KLOW adds KPV to the three peptide GLOW formulation. A supplier that does not clearly distinguish them is not positioned for rigorous research supply.
Health claims or implied human use. Suppliers making such claims operate outside the research use only framework.
Opaque supplier. Legitimate research peptide suppliers have known physical locations.
What KLOW Is Studied For in Research
The KLOW peptide blend research overview covers the full landscape. The short summary is that KLOW is studied in rodent research models for integrated tissue repair, wound healing, anti-inflammatory effects, and angiogenesis. The four component peptides each contribute complementary mechanisms, and the blend allows research on integrated multi peptide effects that extend the three peptide GLOW research.
Research with the individual component peptides is supported by the parallel Midwest Peptide catalog offerings of GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg. KPV is available through the KLOW blend rather than as a standalone product in the standard catalog.
The related three peptide blend is GLOW 20mg, covered in the GLOW research cluster. Research designs that compare KLOW and GLOW directly address the question of what the additional KPV component adds to the three peptide base.
Frequently Asked Sourcing Questions
What is the catalog size? KLOW 90mg per vial, lyophilized powder format.
What is the ratio of the four peptides? The specific ratio is documented on the certificate of analysis for each lot.
What is the purity specification? Each component is supplied at research grade purity with individual values on the third party certificate.
What is the shipping timeline? Two to four business days to continental United States locations with ShipStation and UPS tracking.
What payment methods are accepted? Zelle (five percent discount), CashApp, Venmo, Azeban Pay, Coinbase Commerce.
Are the individual peptides available? Yes. GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg are available as standalone products.
Is the GLOW three peptide blend available for comparison? Yes, GLOW 20mg is available.
Can I request additional documentation? Yes, through the research support line at 636-734-2390.